doi: 10.1016/j.diabet.2023.101470 27 PelleMCZaffinaIGiofreFPujiaRArturiF
Euglycaemic diabetic ketoacidosis is also a concerning adverse effect of SGLT-2 inhibitor use, particularly in people with diabetes, and withdrawal of insulin should be considered in those experiencing starvation and acute sickness
Just as importantly, weight-related comorbidities should be clearly documented if they exist
& Mattsby-Baltzer, I
The reactions catalyzed by glucose-6-phosphate dehydrogenase (G6PD
1) without increasing the incidence of arrhythmia or hospitalization or worsening heart failure [22, 40, 47,48,49,50,51,52,53,54]